The Future of Drug Development: Tweaking the Old Ways
Ah, drug discovery—a world where new ideas often breed as fast as rabbits. Scientist.com is throwing its hat in the ring with an intriguing upcoming webinar crawling with top minds from BioIVT, HUB Organoids, and Cyprotex. These folks are gunning for new approach methodologies, or NAMs as the enlightened call 'em. Scheduled for June 17, 2026, the virtual shindig is packed with talks that might very well reshape how we cook up medicines in labs.
Not Just More Data—It's Better Data
Kevin Lustig, the big cheese running Scientist.com, is betting the farm on NAMs, seeing them as the secret sauce that could ditch sluggish animal testing for slick, human-relevant models. The goal? Predictive and, importantly, scalable methods for research workflows, all said with a nod from keynote backers.
"NAMs are becoming increasingly important as the industry looks for more predictive, scalable and human-relevant approaches to research," said Lustig.
New Faces on Stage: Who's Doing What?
Our first expert, Dr. Courtney Noah from BioIVT, will dive deep into the biological starting materials menu. She’s all about setting the scene for NAM success by sussing out crucial variables right from the start.
Then there’s Dr. René Overmeer, flying under the HUB Organoids flag as part of Merck KGaA. Overmeer’s mission is miniaturizing organoid screening. He’s on the cusp of making these teeny-tiny systems viable for commercial research and development.
Rounding out the trifecta is Dr. Paul Walker, with Cyprotex, laying down insights on using AI to foresee multi-organ toxicity. Sure, it sounds like something out of a sci-fi flick, but the catch here is the reliance on AI-enabled transcriptomic profiling in human models—a true game changer if he’s right.
Panel Mingling or Interrogation?
The event won’t just be a one-way info dump. They’re giving attendees the mic (so to speak), setting up a panel discussion with a shot for some live Q&A. Get your questions ready—the more technical, the better.
Get a Grip on Scientist.com
Even without a ticker symbol to chew on, Scientist.com certainly is a name to know in life sciences, running the show as an AI-backed R&D platform. They’re all about simplifying scientific purchasing by connecting scholars with pre-qualified suppliers—a networking dream.
- Increased innovation via faster supplier discovery
- Ease of access to research services and technologies
- Integrating project reviews and compliance support
Based in Solana Beach, California, they’re creating private, secure academic marketplaces for the big dogs in pharmaceutics, helping to digitize and synchronize scientific workflows globally.
The Bottom Line: Is It Worth Your Time?
For anyone hooked on drug development's pulse and its evolving landscape, this webinar is more than a calendar hole-filler—it’s a chance to be part of the new wave in R&D. Mark your calendars: June 17 is set to be a front-row seat to innovations that might just tweak how the industry's gears grind. Registration’s open now, and you wouldn’t want to miss it—at least if cutting-edge research is your gig.
